Skip to main content
Log in

A comparative study of the pharmacokinetics and pharmacodynamics of atenolol, hydrochlorothiazide and amiloride in normal young and elderly subjects and elderly hypertensive patients

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Six normal young and six normal elderly volunteers and six elderly hypertensive patients took part in an acute and chronic dose study of a combination capsule containing atenolol (50 mg), hydrochlorothiazide (25 mg) and amiloride (2.5 mg) designed for the treatment of hypertension. No difference in any of the drug pharmacokinetic parameters could be detected between the hypertensives and the normal elderly subjects. The bio-availability and the 24-h blood concentrations of all three drugs, half-life of atenolol and amiloride and the peak concentration of hydrochlorothiazide was significantly greater in the elderly. The 24-h blood concentrations of atenolol and hydrochlorothiazide did not alter with chronic dosing, but amiloride concentrations were significantly higher at this time in all groups. A significant fall in the blood pressure was observed in the hypertensive group. Heart rate fell more in the normal and hypertensive elderly subjects than in the young. The combination has shown to be an effective and well tolerated antihypertensive in the elderly patient with a 24-h duration of action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chaudhry AY, Bing RF, Castleden CM, Swales JD, Napier CJ (1984) The Effect of ageing on the response to frusemide in normal subjects. Eur J Clin Pharmacol 27: 303–306

    Google Scholar 

  2. Reeves PR, McAinsh J, McIntosh DAD, Winrow MJ (1978) Metabolism of atenolol in man. Xenobiotica 8 [5]: 313–320

    Google Scholar 

  3. Rubin PC, Scott JWP, McLean K et al. (1982) Atenolol disposition in young and elderly subjects. Br J Clin Pharmacol 13: 235–237

    Google Scholar 

  4. Barber HE, Hawksworth GM, Peartrie JL et al. (1981) Pharmacokinetics of atenolol and propranolol in young and elderly subjects. Br J Clin Pharmacol 11: 118p-119p

    Google Scholar 

  5. Scales B, Copsey PB (1975) The gas chromatographic determination of atenolol in biological samples. J Pharm Pharmacol 27: 430–433

    Google Scholar 

  6. Molholm-Hansen J, Kampmann J, Laursen H (1980) Renal excretion of drugs in elderly. Lancet 1: 1170

    Google Scholar 

  7. O'Malley K, Crookes J, Duke E, Stevenson IH (1971) Effects of age and sex on human drug metabolism. Br Med J 3: 607–609

    Google Scholar 

  8. McAinsh J, Bastain N, Young J, Harry JD (1981) Bioavailability in men of atenolol and chlorthalidone from a combination formulation. Biopharm Drug Dispos 2: 147–156

    Google Scholar 

  9. Godbillon J, Gerardin A, John VA, Theobold N (1983) Comparative pharmacolinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers. Eur J Clin Pharmacol 24: 655–660

    Google Scholar 

  10. Jordo L, Johnson A, Lundborg P et al. (1982) Bioavailability and disposition of metoprolol and hydrochlorothiazide combined in one tablet and of separate doses of hydrochlorothiazide. Br J Clin Pharmacol 14: 727–732

    Google Scholar 

  11. Nichools DP, Harron DHA et al. (1982) Comparative pharmacological and pharmacokinetic observations on propranolol and bendrofluazide administered separately and concurrently to volunteers. Br J Clin Pharmacol 14: 727–732

    Google Scholar 

  12. Roux A, Liboux A, Delhotal B, Gaillot J, Flaurat B (1983) Pharmacokinetics in man of acebutalol and hydrochlorothiazide as single agents and in combination. Eur J Clin Pharmacol 24: 801–806

    Google Scholar 

  13. Klotz U, Arant GR, Hoyumpa A, Schanker S, Wilkinson GR (1975) The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 55: 347–359

    Google Scholar 

  14. Wan SH, Koda RJ, Naronde RF (1979) Pharmacokinetics, pharmacology of atenolol and effects of renal function. Br J Clin Pharmacol 7: 569–574

    Google Scholar 

  15. Sassard J, Pozet N, McKinsh J, Legheand J, Zech P (1973) Pharmacokinetics of atenolol in patients with renal impairment. Eur J Clin Pharmacol 12: 175

    Google Scholar 

  16. Niemeyer C, Hasenfuß A et al. (1983) Pharmacoinetics of hydrochlorothiazide in relation to renal function. Eur J Clin Pharmacol 24: 661–665

    Google Scholar 

  17. Bermann B, Croschinksy-Grind M (1979) Pharmacokinetics of hydrochlorothiazide in patients with congestive heart failure. Br J Clin Pharmacol 7: 579–583

    Google Scholar 

  18. George CF (1980) Amiloride handling in renal failure. Br J Clin Pharmacol 9: 94–95

    Google Scholar 

  19. Sunderam SG, Manikar K (1983) Hyponatraemia in the elderly. Age Ageing 12: 79–89

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sabanathan, K., Castleden, C.M., Adam, H.K. et al. A comparative study of the pharmacokinetics and pharmacodynamics of atenolol, hydrochlorothiazide and amiloride in normal young and elderly subjects and elderly hypertensive patients. Eur J Clin Pharmacol 32, 53–60 (1987). https://doi.org/10.1007/BF00609957

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00609957

Key words

Navigation